AG
BHVN

Artal Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Artal Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-400,000
Closed -$38.8M – 163
2021
Q2 		$38.8M Buy
+400,000
New +$38.8M 0.79% 23
2017
Q4 		– Sell
-50,000
Closed -$1.87M – 124
2017
Q3 		$1.87M Buy
+50,000
New +$1.87M 0.03% 65